Preventing Alzheimer's With Cognitive Training

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age65+
SponsorUniversity of South Florida

About this trial

Dementia is the most expensive medical condition in the US and increases in prevalence with age. More than 5 million Americans have Alzheimer's disease, the most common form of dementia. Mild cognitive impairment is a transitional stage between normal cognitive aging and Alzheimer's disease or another type of dementia, and is indicative of higher risk for dementia. In addition to the obvious health and quality-of-life ramifications of dementia, there are high direct (e.g., subsidizing residential care needs) and indirect (e.g., lost productivity of family caregivers) economic costs. Implementing interventions to prevent MCI and dementia among older adults is of critical importance to health and maintained quality-of-life for millions of Americans. Recent data analyses from the Advanced Cognitive Training in Vital Elderly study (ACTIVE) indicate that a specific cognitive intervention, speed of processing training (SPT), significantly delays the incidence of cognitive impairment across 10 years. The primary contribution of the proposed research will be the determination of whether this cognitive training technique successfully delays the onset of clinically defined MCI or dementia across three years.

Eligibility criteria

Qualifiers

Be age 65 or older at time of consent

Have ability to speak and understand English or Spanish

Report adequate sensorimotor capacity to perform the computer exercises

Report adequate visual capacity to read from a computer screen at a typical viewing distance

Disqualifiers

Currently enrolled in another randomized clinical trial, treatment trial, or another research study that assesses cognition

Previous participation in a cognitive training study

Self-reported vision, hearing, or motor difficulties that would interfere with the ability to complete the study interventions

Self-reported diagnosis of mild cognitive impairment, dementia, stroke, traumatic brain injury, brain tumor, or a neurological disorder that affects cognition or would interfere with the ability to benefit from the study intervention (e.g., Parkinson disease, multiple sclerosis), or any other unstable medical conditions that is predisposing to imminent cognitive or functional decline (e.g., congestive heart failure, chronic obstructive pulmonary disorder dependent on oxygen, or undergoing chemotherapy or radiation).

Trial design

Treatments tested in this trial

  • Cognitive Training
  • Computerized Cognitive Stimulation

Treatment groups

7,600 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of South Florida

Lead sponsor

National Institute on Aging (NIA)

Collaborator